Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Pharmacologic alternatives in statin-intolerant patients include ezetimibe and nutraceuticals
(i.e. compounds derived from foods with cholesterol lowering actions). The investigators will
compare the efficacy and tolerability of ezetimibe versus a nutraceutical-based protocol in
statin-intolerant patients treated with percutaneous coronary intervention.